AzTrials
AzTrials

PainPhase 2NCT05223075

Articaine Versus Lidocaine Buccal Infiltration

A Phase 2 study testing articaine local anethesia with vasoconstrictor and lidocaine local anethesia with vasoconstrictor in people with Pain, run by Fayoum University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

assess the effect of articaine versus lidocaine in only buccal infiltration of local anethesia in lower anterior teeth Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Pain
What is being tested?
articaine local anethesia with vasoconstrictor and lidocaine local anethesia with vasoconstrictor
Could I receive a placebo?
No, everyone receives an active treatment
How many people
31 participants
Where
1 siteEgypt
Study dates
11 Nov 2022to 2 Mar 2023
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • medically stable
  • 18years or older
  • patient with bilateral lower anterior teeth requiring non surgical removal

Who cannot join

  • grade 3 mobility
  • neurological disease
  • allergy to anethesia

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Fayoum University

    Al Fayyum

Other trials in Egypt

About this study

Official title: Articaine Versus Lidocaine in Only Buccal Infiltration Anesthesia for the Extraction of Mandibular Anterior Teeth.Asplit Mouth Clinical Trail

assess the effect of articaine versus lidocaine in only buccal infiltration of local anethesia in lower anterior teeth

Conditions
Pain
Being tested
articaine local anethesia with vasoconstrictor, lidocaine local anethesia with vasoconstrictor
Keywords
buccal infiltration, lidocaine, articaine
Medical subject headings
Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • articaine local anethesia with vasoconstrictorDrug

    buccal infiltration only of articaine local anethesia during extraction of lower anterior teeth

  • lidocaine local anethesia with vasoconstrictorDrug

    buccal infiltration only of lidocaine local anethesia during extraction of lower anterior teeth

Study groups in NCT05223075
Study groupRoleWhat they receive
articaine groupExperimentalNot described
Receives: Drug: articaine local anethesia with vasoconstrictor
lidocaine groupExperimentalNot described
Receives: Drug: lidocaine local anethesia with vasoconstrictor

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. pain during extraction

    by (VAS) visual analouge scale

    Measured: during extraction

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Feb 2022
  2. Study start11 Nov 2022
  3. Primary completion28 Feb 2023 (estimated)
  4. Study completion2 Mar 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
31 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05223075
Sponsor's protocol ID
256-06/2018
Status last verified
Feb 2023
First submitted
23 Jan 2022
Last updated
15 Feb 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Al-Mahalawy H, El-Mahallawy Y, Abdelrahman HH, Refahee SM. Articaine versus Lidocaine in only buccal infiltration anesthesia for the extraction of mandibular anterior teeth. A prospective split-mouth randomized-controlled clinical study. BMC Oral Health. 2023 Aug 28;23(1):604. doi: 10.1186/s12903-023-03292-5.

    PubMed 37641122

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing articaine local anethesia with vasoconstrictor and lidocaine local anethesia with vasoconstrictor in people with Pain, run by Fayoum University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 15 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

pain during extraction (time frame: during extraction). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05223075, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Feb 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in